HRG reviewed 12 products in the health category, 125 items in the wellness sector and 92 products in the beauty aisle to see ...

Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at ...

[TOKYO] Hisamitsu Pharmaceutical’s management is considering a takeover bid to privatise the Japanese maker of pain-relief patches in a deal that could be worth around 450 billion yen (S$3.7 billion), ...

Hisamitsu, known for its Salonpas pain-relief patches, joins a growing list of Japanese companies exiting the public market. (Jan 6): Hisamitsu Pharmaceutical Co’s management is considering a takeover ...

Hisamitsu Pharmaceutical Co. is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be valued at about ¥450 billion ($2.9 billion), according to ...

Stress and anxiety can worsen pain by causing muscles to get tense or spasm and by raising levels of the inflammation-inducing hormone cortisol. Plus, pain signals can be dialed up or down depending ...

A widely prescribed opioid painkiller showed limited effectiveness and increased risk of negative effects in a new analysis published in BMJ Evidence-Based Medicine. The study examined tramadol, a ...

A new weight-loss drug that Eli Lilly is testing is helping patients in a late-stage trial lose an average of 28.7% of their body weight and offered "substantial" relief from osteoarthritis pain. In ...

Q: Journavx works for me! I rarely need an opioid like Norco (hydrocodone and acetaminophen) or an NSAID like Celebrex when I’m on it. Now my pain specialist says it is limited to three months a year.

OKLAHOMA CITY (KFOR) — One Oklahoma Nurse Practitioner is trying to provide relief for patients by using a drug-free option. It’s approved by the FDA, and after Congress implemented the No Pain Act in ...